CAR-T cell therapy (Prime Medicine)

N/A

Report date: 2024/09/04 15:10:14

Base Information

Drug NameCAR-T cell therapy (Prime Medicine)
Drug Alias Nameex vivo CAR-T cell therapy (Prime Medicine)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrime Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrime Medicine Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A